Phio Pharmaceuticals (PHIO) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:33:37.054Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:33:37.054Z.

Quote observation: 2026-10-06T17:27:37.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.99
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.34

FMP input reference: ca628ff6f55b6345e2cefca22780bd34dfabddebf8a5c62bf0c86d2d29f40561

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

PHIO PE Ratio Metrics

PE RATIO

N/A

PHIO Competitors' PE Ratio

PHIO

Phio Pharmaceuticals Corp.

Current

Market Cap

$11.50M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRI

Biofrontera Inc.

vs PHIO

Market Cap

$11.40M

PE Ratio

N/A

TTM Avg

9.63

3Y Avg

9.63

5Y Avg

9.63

ADIL

Adial Pharmaceuticals, Inc.

vs PHIO

Market Cap

$11.32M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs PHIO

Market Cap

$11.20M

PE Ratio

N/A

TTM Avg

2.09

3Y Avg

2.09

5Y Avg

2.09

KPRX

Kiora Pharmaceuticals, Inc.

vs PHIO

Market Cap

$11.12M

PE Ratio

N/A

TTM Avg

2.43

3Y Avg

2.43

5Y Avg

2.43

BIVI

BioVie Inc.

vs PHIO

Market Cap

$11.09M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs PHIO

Market Cap

$10.91M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRIX

IRIDEX Corporation

vs PHIO

Market Cap

$12.28M

PE Ratio

N/A

TTM Avg

245.86

3Y Avg

105.92

5Y Avg

78.24

CNSY

Cerenome, Inc.

vs PHIO

Market Cap

$10.81M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRG

Bullfrog AI Holdings, Inc. Common Stock

vs PHIO

Market Cap

$12.33M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Phio Pharmaceuticals Corp. (PHIO)	$11.50M	N/A	N/A	N/A	N/A
Biofrontera Inc. (BFRI)vs ›	$11.40M	N/A	9.63	9.63	9.63
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.32M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.20M	N/A	2.09	2.09	2.09
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.12M	N/A	2.43	2.43	2.43
BioVie Inc. (BIVI)vs ›	$11.09M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.91M	N/A	N/A	N/A	N/A
IRIDEX Corporation (IRIX)vs ›	$12.28M	N/A	245.86	105.92	78.24
Cerenome, Inc. (CNSY)vs ›	$10.81M	N/A	N/A	N/A	N/A
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$12.33M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.99

÷

Forward EPS (Est.)

$-1.44

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

PHIO PE Ratio Metrics

PHIO Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics